Other Online events

Can we cure cancer?

Past event - 2021
20 May Streaming from
8:30-9:30PM Eastern
8:00-9:00PM Central
6:30-7:30PM Western
Online, YouTube,
Online Your Home
It is estimated that one in two Australians will, by the age of 85, be diagnosed with cancer. Until recently we’ve had three basic treatment options - surgery, radiation, and chemotherapy - but these treatment methods will not be effective in all cases. Australian researchers are at the forefront of discovering new therapies that improve patient outcomes. Join our host Clare Fedele and panelists as we discuss new frontiers for cancer treatments and explore advances in personalised medicine.

Hosted by

Dr Clare Fedele (Senior postdoctoral researcher, project manager)
Dr Clare Fedele is a cancer scientist at the University of Melbourne Centre for Cancer Research, and passionate science communicator. She has received prestigious fellowships from NHMRC and Victorian Cancer Agency, and in 2017 was named a Superstar of STEM by Science and Technology Australia.

Blood, bone, and stem cells

Associate Professor Nada Hamad (Staff Specialist Haematologist and President of ANZTCT)
Nada is a senior staff specialist in bone marrow transplant, cellular therapies, clinical and laboratory haematologist at Sydney’s St. Vincent’s hospital, where she is also the director of the haematology clinical trials unit. Nada is currently the President of the Bone Marrow Transplant Society of Australia and also lectures at the University of Sydney and UNSW. She main research interests are in malignant haematology and bone marrow transplantation.

Prevention is key!

Dr Eleonora Feletto (Senior Research Fellow)
Dr Eleonora Feletto is a research fellow at Cancer Council NSW, where she leads the Gastrointestinal Cancers group. Her research focuses on areas of cancer control, cancer environmental risk factors, implementation of health services in practice, and the use of alternative channels to build a sustainable health care system. In particular, Eleonora is interested in cancer prevention and early detection of colorectal and liver cancer in Australia.

Nanosize particles to treat cancer

Dr Nick Fletcher (Postdoctoral Researcher)
Nanomedicine can provide a step-change in treatment options for many diseases, including cancer. My research in particular has focused on improving our understanding of how nanomaterials interact with the body after injection, as well as approaches to modulate these interactions to improve treatment outcomes.

Nicholas completed his PhD at UQ in 2015 focused on self-assembling peptides. Since then he has worked as a research fellow focused on the development of nanomedicines primarily for the treatment of cancer and is currently working to expand his independent research program and group.

Is education our best cure for cancer?

Dr Ken Dutton-Regester (Founder and Director of Excite Science, Research Officer)
We always say 'prevention is better than cure', so why is our investment in preventative cancer education so dismal compared to our investment in late stage treatment? In this panel, I'll be outlining the challenges in cancer education and explain how I'm using creative outreach underpinned by science to 'cure' cancer.

Dr Ken Dutton-Regester is the founder and director of Excite Science, a creative studio developing educational and immersive cancer-themed pop-up experiences. He is also an active cancer researcher at QIMR Berghofer Medical Research Institute exploring the genetics of melanoma.

Other Online events

YouTube, Online, Your Home, Australia YouTube, Online, Your Home, Australia
YouTube, Online, Your Home, Australia YouTube, Online, Your Home, Australia